SIGIRR/TIR8, an important regulator of TLR4 and IL-1R–mediated NF-κB activation, predicts biochemical recurrence after prostatectomy in low-grade prostate carcinomas
- 1 November 2015
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 46 (11) , 1744-1751
Abstract
No abstract availableKeywords
Funding Information
- UW Department of Pathology and Laboratory Medicine and UWCCC (P30 CA014520)
This publication has 30 references indexed in Scilit:
- HP1γ expression is elevated in prostate cancer and is superior to Gleason score as a predictor of biochemical recurrence after radical prostatectomyBMC Cancer, 2013
- TIR8/SIGIRR is an Interleukin-1 Receptor/Toll Like Receptor Family Member with Regulatory Functions in Inflammation and ImmunityFrontiers in Immunology, 2012
- Inflammation meets cancer, with NF-κB as the matchmakerNature Immunology, 2011
- Loss of Single Immunoglobulin Interlukin-1 Receptor-Related Molecule Leads to Enhanced Colonic Polyposis in Apcmin MiceGastroenterology, 2010
- Impacts of Antibiotic and Anti-Inflammatory Therapies on Serum Prostate-Specific Antigen Levels in the Presence of Prostatic Inflammation: A Prospective Randomized Controlled TrialUrologia Internationalis, 2010
- The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE TrialEuropean Urology, 2008
- Improved prediction of prostate cancer recurrence through systems pathologyJournal of Clinical Investigation, 2007
- Inflammation in prostate carcinogenesisNature Reviews Cancer, 2007
- SIGIRR Inhibits Interleukin-1 Receptor- and Toll-like Receptor 4-mediated Signaling through Different MechanismsJournal of Biological Chemistry, 2005
- IDENTIFICATION AND CHARACTERIZATION OF SIGIRR, A MOLECULE REPRESENTING A NOVEL SUBTYPE OF THE IL-1R SUPERFAMILYCytokine, 1999